Souvenaid® is for people who are in the early stages of Alzheimer’s disease. The clinical benefit of Souvenaid® has so far only been demonstrated in people during the early stages of Alzheimer’s disease. Souvenaid® must be used under medical supervision.
Souvenaid® is a single serve drink making it easy and convenient for people to take. It can be consumed straight from the bottle, through a straw or popped into a glass. It comes in three flavours; vanilla, strawberry and cappuccino. It tastes best served chilled, so we recommend keeping a few bottles in the fridge. Alternatively if you want to turn your daily Souvenaid® into a delicious creation, check out our great range of recipes.
Souvenaid® is food for special medical purposes for the dietary management of patients diagnosed with mild/early Alzheimer’s disease. It must be used under medical supervision. Clinical studies have demonstrated that Souvenaid® can be used safely alongside commonly prescribed Alzheimer’s disease medication.
Souvenaid® is indicated for the dietary management of patients with early Alzheimer’s disease. Souvenaid® has not been tested in people who do not have Alzheimer’s disease. You should consult your health care professional about whether it is appropriate to take Souvenaid®.
Souvenaid® is an Food for Special Medical Purpose for the dietary management of early Alzheimer’s disease. It is not intended to prevent the disease nor is it a treatment and it should only be used by people who have already been diagnosed with early Alzheimer’s disease. It must be used under medical supervision.
Souvenaid® is a medical nutrition drink clinically proven to be beneficial in the dietary management of people with early Alzheimer’s disease. Clinical trials of Souvenaid® in combination with coconut oil or food supplements have not been carried out.
This question is best answered by your healthcare professional. Clinical trials directly comparing Souvenaid® with fish oil and vitamin supplements have not been carried out.
Souvenaid® contains a unique combination of nutrients at levels difficult to achieve from diet alone. In early Alzheimer’s disease, dietary intake of nutrients may be affected by worsening of appetite, taste and smell, which lead to reduced food consumption, food neglect and changes in food preferences.
In addition, research suggests that people with early Alzheimer’s disease have higher requirements than people without the disease for certain nutrients supporting brain function. It would be extremely difficult to modify your diet to achieve the right combination of specific nutrients and unreasonable to expect people to eat enough of the right foods.
Souvenaid® is not suitable for patients with galactosaemia. Galactosaemia is a genetic disease where a person cannot metabolise galactose.
Upon recommendation by your healthcare professional, Souvenaid® can be purchased directly from our online store or from your local pharmacy.
To see if this product is right for you, please contact your healthcare professional. Alternatively if you have specific questions about the product, please call the Souvenaid® customer care team on 1800 438 500 if you are calling from Australia or 0800 688 742 if you are calling from New Zealand.
DISCLAIMER:
Souvenaid® is a Food for Special Medical Purpose for the dietary management of early Alzheimer’s disease. Must be used under medical supervision.
The information on this page is not intended to be a substitute for medical advice. Always seek medical advice from a healthcare professional.